<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02741089</url>
  </required_header>
  <id_info>
    <org_study_id>15-149</org_study_id>
    <nct_id>NCT02741089</nct_id>
  </id_info>
  <brief_title>Bronchoscopy Registry</brief_title>
  <acronym>BSK</acronym>
  <official_title>Bronchoscopy Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This monocentric, non-interventional observational registry study was designed in order to
      obtain data of patients with the indication for a flexible bronchoscopy to control and
      optimize a guideline conform therapy of these patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aims of this registry study are documentation of the characteristics of all patients with an
      indication for a flexible bronchoscopy who are attended at the University Hospital Aachen
      (UKA) to obtain new knowledge concerning safety and patient comfort using different
      medications for sedation.

      Therefore a routine flexible bronchoscopy is carried out, whereat the choice of
      analgosedation medication is for the investigators decision, independent from the study.

      Subsequently the following data are collected:

        -  duration of medical examination

        -  medication (e.g. midazolam, fentanyl, propofol, lidocain)

        -  vital signs at the end of the examination

        -  complications

      Furthermore the patient should be asked concerning the general tolerance for the procedure
      and different symptoms like emesis, feeling of suffocation, cough and pain (0 = no stress,
      100 = intolerable). In addition to that the grade of amnesia and the acceptance for later
      bronchoscopies should be asked.

      Analyzing this data will optimize the internal quality control concerning the conducted
      examination, collect all complications related to the analgosedation and enhance the patients
      comfort during a flexible bronchoscopy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">February 2020</completion_date>
  <primary_completion_date type="Anticipated">February 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>demographic data</measure>
    <time_frame>20 minutes (before the routine intervention)</time_frame>
    <description>Physiological parameters to assure internal quality control regarding the flexible bronchoscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>indication for flexible bronchoscopy</measure>
    <time_frame>10 minutes (before the routine intervention)</time_frame>
    <description>physiological parameters to assure internal quality control regarding the flexible bronchoscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>smoking behaviour</measure>
    <time_frame>1 minute (before the routine intervention)</time_frame>
    <description>physiological parameters to assure internal quality control regarding the flexible bronchoscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>relevant side diseases</measure>
    <time_frame>10 minutes (before the routine intervention)</time_frame>
    <description>physiological parameters to assure internal quality control regarding the flexible bronchoscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>lung function parameters</measure>
    <time_frame>30 minutes (before the routine intervention)</time_frame>
    <description>physiological parameters to assure internal quality control regarding the flexible bronchoscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>anesthetic risk (ASA-Score)</measure>
    <time_frame>10 minutes (before the routine intervention)</time_frame>
    <description>physiological parameters to assure internal quality control regarding the flexible bronchoscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>vital signs</measure>
    <time_frame>10 minutes (before and after the routine intervention)</time_frame>
    <description>physiological parameters to assure internal quality control regarding the flexible bronchoscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>detection of complications depending on the different analgosedations</measure>
    <time_frame>30 minutes (during the routine intervention)</time_frame>
    <description>physiological parameters to assure internal quality control regarding the flexible bronchoscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>duration of medical examination</measure>
    <time_frame>30 minutes (during the routine intervention)</time_frame>
    <description>physiological parameters to assure internal quality control regarding the flexible bronchoscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>medication (e.g. midazolam, fentanyl, propofol, lidocain)</measure>
    <time_frame>5 minutes (after routine intervention)</time_frame>
    <description>physiological parameters to assure internal quality control regarding the flexible bronchoscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>general tolerance for the procedure and different symptoms like emesis, feeling of suffocation, cough and pain (0 = no stress, 100 = intolerable)</measure>
    <time_frame>5 minutes (after routine intervention)</time_frame>
    <description>questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>grade of amnesia</measure>
    <time_frame>5 minutes (after routine intervention)</time_frame>
    <description>questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>acceptance for later bronchoscopies</measure>
    <time_frame>5 minutes (after routine intervention)</time_frame>
    <description>questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>identification of prognostic factors related to complications</measure>
    <time_frame>30 minutes (during the routine intervention)</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Indications for Flexible Bronchoscopy</condition>
  <arm_group>
    <arm_group_label>Indication for a flexible bronchoscopy</arm_group_label>
    <description>Patients representing to the hospital with the indication for a flexible bronchoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Indication for a flexible bronchoscopy</intervention_name>
    <description>The data of patients are collected within the hospital routine documentation during the flexible bronchoscopy. The bronchoscopy is performed regardless of this study. Following the bronchoscopy the patients are asked a few questions about their health and their perception.
The follow-up of all patients is done via phone calls in order to collect data about the outcome of each patient.</description>
    <arm_group_label>Indication for a flexible bronchoscopy</arm_group_label>
  </intervention>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, Blood plasm
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with the medical indication for a flexible bronchoscopy by the attending
        physicians
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written declaration of consent

          -  Patients with the medical indication for a flexible bronchoscopy

        Exclusion Criteria:

          -  Patients who are not fulfilling the inclusion criteria or:

          -  Pregnant or breastfeeding women

          -  Participation in other studies

          -  Sponsor-dependent patients or patients who are working with the sponsor

          -  Patients without mental ability or capacity to understand and follow the instructions
             of the investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Dreher, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>RWTH Aachen University Hospital, MK1</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tobias Müller, PD</last_name>
    <role>Principal Investigator</role>
    <affiliation>RWTH Aachen University Hospital, MK1</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tobias Müller</last_name>
    <phone>00492418035768</phone>
    <email>tobmueller@ukaachen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Angela Habier</last_name>
    <phone>004924180</phone>
    <phone_ext>37429</phone_ext>
    <email>ahabier@ukaachen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Aachen, Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine</name>
      <address>
        <city>Aachen</city>
        <state>NRW</state>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Müller, PD</last_name>
      <phone>004924180</phone>
      <phone_ext>36470</phone_ext>
      <email>tobmueller@ukaachen.de</email>
    </contact>
    <contact_backup>
      <last_name>Angela Habier</last_name>
      <phone>004924180</phone>
      <phone_ext>37429</phone_ext>
      <email>ahabier@ukaachen.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2016</study_first_submitted>
  <study_first_submitted_qc>April 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2016</study_first_posted>
  <last_update_submitted>April 7, 2017</last_update_submitted>
  <last_update_submitted_qc>April 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Analgosedation</keyword>
  <keyword>Internal Quality Assurance</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

